SPC for Fostair® updated for new indication for maintenance and reliever therapy

Source: Personal communication Area: News Section 4.2 of the Summary of Product Characteristics (SPC) for Fostair (beclometasone dipropionate/formoterol) pressurised metered dose inhaler (pMDI) has been updated to include a new indication of Maintenance and Reliever Therapy. Under these circumstances, patients take their daily maintenance dose of Fostair and in addition take Fostair as needed in response to asthma symptoms. Patients using Fostair in this way should be advised to always have Fostair available for rescue use.
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news